Page last updated: 2024-08-17

adenosine monophosphate and Cardiomyopathy, Hypertrophic

adenosine monophosphate has been researched along with Cardiomyopathy, Hypertrophic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gray, A; Hardie, DG; Padbury, J; Phornphutkul, C; Shaw, S; Tseng, YT; Uzun, A; Xu, Y	1
Akman, HO; Benson, L; Bruno, C; Dimauro, S; Hardie, DG; Ross, FA; Sampayo, JN; Scott, JW; Shanske, S; Wilson, G	1

Other Studies

2 other study(ies) available for adenosine monophosphate and Cardiomyopathy, Hypertrophic

Article	Year
A novel, de novo mutation in the American journal of physiology. Heart and circulatory physiology, 2017, Aug-01, Volume: 313, Issue:2 Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Carrier Proteins; Case-Control Studies; DNA Mutational Analysis; Enzyme Activation; Fibroblasts; Genetic Predisposition to Disease; HEK293 Cells; Humans; Infant, Newborn; Intracellular Signaling Peptides and Proteins; Models, Molecular; Mutation, Missense; Myocytes, Cardiac; Phenformin; Phenotype; Phosphoproteins; Phosphorylation; Protein Conformation; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Transfection	2017
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Pediatric research, 2007, Volume: 62, Issue:4 Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Fatal Outcome; Female; Glycogen; Glycogen Storage Disease; Humans; Infant, Newborn; Multienzyme Complexes; Mutation; Myocardium; Phosphorylase Kinase; Protein Serine-Threonine Kinases	2007

Article

Year

A novel, de novo mutation in the

American journal of physiology. Heart and circulatory physiology, 2017, Aug-01, Volume: 313, Issue:2

Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Carrier Proteins; Case-Control Studies; DNA Mutational Analysis; Enzyme Activation; Fibroblasts; Genetic Predisposition to Disease; HEK293 Cells; Humans; Infant, Newborn; Intracellular Signaling Peptides and Proteins; Models, Molecular; Mutation, Missense; Myocytes, Cardiac; Phenformin; Phenotype; Phosphoproteins; Phosphorylation; Protein Conformation; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Transfection

2017

Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.

Pediatric research, 2007, Volume: 62, Issue:4

Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Fatal Outcome; Female; Glycogen; Glycogen Storage Disease; Humans; Infant, Newborn; Multienzyme Complexes; Mutation; Myocardium; Phosphorylase Kinase; Protein Serine-Threonine Kinases

2007